SCHEMBL7070299

SCHEMBL7070299

COC(CNc1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2ncnc(NCc3ccccc3)c12)OC

nearest known ligand 0.66

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ HTR2B P41595 6/20 0.66
▸ SIGMAR1 Q99720 5/20 0.66
▸ TMEM97 Q5BJF2 4/20 0.66
▸ OPRK1 P41145 2/20 0.66
▸ ADRA2C P18825 1/20 0.66
▸ HTR6 P50406 1/20 0.66
▸ ADORA3 P0DMS8 3/20 0.59
▸ TP53 P04637 1/20 0.59
▸ SLC29A1 Q99808 1/20 0.59
▸ TDP1 Q9NUW8 1/20 0.59
▸ ADK P55263 5/20 0.57
▸ ADORA2A P29274 1/20 0.52
▸ ADORA2B P29275 1/20 0.52
▸ ADORA1 P30542 1/20 0.52
▸ HTR1D P28221 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7070066 0.82 ADK (0.79) HTR2BSIGMAR1TMEM97OPRK1ADRA2C
SCHEMBL7074340 0.79 SIGMAR1 (0.83) HTR2BSIGMAR1TMEM97OPRK1ADRA2C
SCHEMBL7077466 0.79 HTR2B (0.69) HTR2BSIGMAR1TMEM97OPRK1ADRA2C
SCHEMBL7077959 0.78 SIGMAR1 (0.81) HTR2BSIGMAR1TMEM97OPRK1ADRA2C
SCHEMBL7070318 0.77 HTR2B (0.69) HTR2BSIGMAR1TMEM97OPRK1ADRA2C
SCHEMBL8331212 0.77 ADK (0.71) HTR2BSIGMAR1TMEM97OPRK1ADRA2C
SCHEMBL15477884 0.76 METTL3 (0.79) HTR2BSIGMAR1TMEM97OPRK1ADRA2C
SCHEMBL15570446 0.76 METTL3 (0.79) HTR2BSIGMAR1TMEM97OPRK1ADRA2C
SCHEMBL16941466 0.76 METTL3 (0.79) HTR2BSIGMAR1TMEM97OPRK1ADRA2C
SCHEMBL8332977 0.75 ADORA3 (0.69) HTR2BSIGMAR1TMEM97OPRK1ADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003051899-A1 DEAZAPURINE NUCLEOSIDE LIBRARIES AND COMPOUNDS RIBAPHARM INC. (US) 2003-06-26 — — WO disclosed
Send feedback